{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:31:48Z","timestamp":1773009108974,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,8]]},"DOI":"10.7759\/cureus.14361","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T08:30:13Z","timestamp":1617870613000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind, Multicenter Study"],"prefix":"10.7759","author":[{"given":"Shubhadeep D","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saroj K","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leela","family":"Talluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh K","family":"Bhashyakarla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umadevi","family":"Malladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupal  V","family":"Dosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh K","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreenivasa","family":"Chary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini V","year":"2016","unstructured":"Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal disorders. Gastroenterology. 2016, 150:1380-92. 10.1053\/j.gastro.2016.02.011","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12089.1","article-title":"The management of functional dyspepsia in clinical practice: what lessons can be learnt from recent literature?","volume":"6","author":"Corsetti M","year":"2017","unstructured":"Corsetti M, Fox M. The management of functional dyspepsia in clinical practice: what lessons can be learnt from recent literature?. F1000Res. 2017, 6:1778. 10.12688\/f1000research.12089.1","journal-title":"F1000Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000128576","article-title":"An international comparison of the burden of illness in patients with dyspepsia","volume":"26","author":"Halling K","year":"2008","unstructured":"Halling K, Kulich K, Carlsson J, Wiklund I. An international comparison of the burden of illness in patients with dyspepsia. Dig Dis. 2008, 26:264-73. 10.1159\/000128576","journal-title":"Dig Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis","volume":"64","author":"Ford AC","year":"2015","unstructured":"Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015, 64:1049-57. 10.1136\/gutjnl-2014-307843","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01180.x","article-title":"Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia","volume":"16","author":"Distrutti E","year":"2002","unstructured":"Distrutti E, Fiorucci S, Hauer SK, Pensi MO, Vanasia M, Morelli A. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment Pharmacol Ther. 2002, 16:613-22. 10.1046\/j.1365-2036.2002.01180.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.562890","article-title":"Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia","volume":"20","author":"Tack J","year":"2011","unstructured":"Tack J, Janssen P. Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia. Expert Opin Investig Drugs. 2011, 20:701-12. 10.1517\/13543784.2011.562890","journal-title":"Expert Opin Investig Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.020","article-title":"American gastroenterological association technical review on the evaluation of dyspepsia","volume":"129","author":"Talley NJ","year":"2005","unstructured":"Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005, 129:1756-80. 10.1053\/j.gastro.2005.09.020","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2012.01897.x","article-title":"Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography","volume":"24","author":"Kusunoki H","year":"2012","unstructured":"Kusunoki H, Haruma K, Manabe N, et al.. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol Motil. 2012, 24:540-5, e250-1. 10.1111\/j.1365-2982.2012.01897.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref9","unstructured":"A Phase III, multi-center, double blind, comparative, active-control, parallel group, randomized, study to evaluate the efficacy and safety of acotiamide ER 300mg in Indian adult patients with functional dyspepsia-post prandial distress syndrome, CTRI\/2019\/11\/021897. (2021). Accessed. January 12, 2021: http:\/\/ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=37568&EncHid=&userName=CTRI\/2019\/11\/021897."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02774.x","article-title":"Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials","volume":"23","author":"Veldhuyzen van Zanten SJ","year":"2006","unstructured":"Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, et al.. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Aliment Pharmacol Ther. 2006, 23:521-9. 10.1111\/j.1365-2036.2006.02774.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00900.x","article-title":"Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form","volume":"15","author":"Talley NJ","year":"2001","unstructured":"Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001, 15:207-16. 10.1046\/j.1365-2036.2001.00900.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.003","article-title":"Functional dyspepsia impacts absenteeism and direct and indirect costs","volume":"8","author":"Brook RA","year":"2010","unstructured":"Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010, 8:498-503. 10.1016\/j.cgh.2010.03.003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000358111","article-title":"Therapeutic options for functional dyspepsia","volume":"32","author":"Vanheel H","year":"2014","unstructured":"Vanheel H, Tack J. Therapeutic options for functional dyspepsia. Dig Dis. 2014, 32:230-4. 10.1159\/000358111","journal-title":"Dig Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01449.x","article-title":"Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage","volume":"22","author":"Matsueda K","year":"2010","unstructured":"Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage. Neurogastroenterol Motil. 2010, 22:618-e173. 10.1111\/j.1365-2982.2009.01449.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref15","article-title":"Efficacy and safety assessment of Acotiamide and Levosulpiride in functional dyspepsia","volume":"16","author":"Behera R","year":"2017","unstructured":"Behera R, Sethi S. Efficacy and safety assessment of Acotiamide and Levosulpiride in functional dyspepsia. J Dent Med Sci. 2017, 16:53-7.","journal-title":"J Dent Med Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4172\/2161-069X.1000553","article-title":"Real world efficacy and tolerability of acotiamide, in relieving meal-related symptoms of functional dyspepsia","volume":"8","author":"Narayanan V","year":"2018","unstructured":"Narayanan V, Bhargava A, Pallewar S. Real world efficacy and tolerability of acotiamide, in relieving meal-related symptoms of functional dyspepsia. J Gastrointest Dig Syst. 2018, 8:553. 10.4172\/2161-069X.1000553","journal-title":"J Gastrointest Dig Syst"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301454","article-title":"A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia","volume":"61","author":"Matsueda K","year":"2012","unstructured":"Matsueda K, Hongo M, Tack J, Saito Y, Kato H. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012, 61:821-8. 10.1136\/gutjnl-2011-301454","journal-title":"Gut"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/52409-efficacy-and-safety-of-orally-administered-acotiamide-extended-release-tablets-among-functional-dyspepsia-postprandial-distress-syndrome-patients-a-randomized-double-blind-multicenter-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:53Z","timestamp":1707507113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/52409-efficacy-and-safety-of-orally-administered-acotiamide-extended-release-tablets-among-functional-dyspepsia-postprandial-distress-syndrome-patients-a-randomized-double-blind-multicenter-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.14361","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}